The transcription factor NRF2 protects against pulmonary fibrosis
- 4 June 2004
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 18 (11), 1258-1260
- https://doi.org/10.1096/fj.03-1127fje
Abstract
The molecular mechanisms of pulmonary fibrosis are poorly understood, although reactive oxygen species are thought to have an important role. NRF2 is a transcription factor that protects cells and tissues from oxidative stress by activating protective antioxidant and detoxifying enzymes. We hypothesized that NRF2 protects lungs from injury and fibrosis induced by bleomycin, an anti-neoplastic agent that causes pulmonary fibrosis in susceptible patients. To test this hypothesis, mice with targeted deletion of Nrf2 (Nrf2-/-) and wild-type (Nrf2+/+) mice were treated with bleomycin or vehicle, and pulmonary injury and fibrotic responses were compared. Bleomycin-induced increases in lung weight, epithelial cell death, and inflammation were significantly greater in Nrf2-/- mice than in Nrf2+/+ mice. Indices of lung fibrosis (hydroxyproline content, collagen accumulation, fibrotic score, cell proliferation) were significantly greater in bleomycin-treated Nrf2-/- mice, compared with Nrf2+/+ mice. NRF2 expression and activity were elevated in Nrf2+/+ mice by bleomycin. Bleomycin caused greater up-regulation of several NRF2-inducible antioxidant enzyme genes and protein products in Nrf2+/+ mice compared with Nrf2-/- mice. Further, bleomycin-induced transcripts and protein levels of lung injury and fibrosis markers were significantly attenuated in Nrf2+/+ mice compared with Nrf2-/- mice. Results demonstrated that NRF2 has a critical role in protection against pulmonary fibrosis, presumably through enhancement of cellular antioxidant capacity. This study has important implications for the development of intervention strategies against fibrosis.Keywords
Funding Information
- National Institutes of Health (ES-03819, HL-66109)
- National Institute of Environmental Health Sciences
This publication has 39 references indexed in Scilit:
- Transcriptional activation of the type I collagen genes COL1A1 and COL1A2 in fibroblasts by interleukin‐4: Analysis of the functional collagen promoter sequencesJournal of Cellular Physiology, 2003
- Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosisThe Journal of Pathology, 2003
- Enhanced Expression of the Transcription Factor Nrf2 by Cancer Chemopreventive Agents: Role of Antioxidant Response Element-Like Sequences in the nrf2 PromoterMolecular and Cellular Biology, 2002
- Accelerated DNA Adduct Formation in the Lung of the Nrf2 Knockout Mouse Exposed to Diesel ExhaustToxicology and Applied Pharmacology, 2001
- Expression of thioredoxin in bleomycin-injured airway epithelium: Possible role of protection against bleomycin induced epithelial injuryLife Sciences, 2001
- Gelatinase B Is Required for Alveolar Bronchiolization after Intratracheal BleomycinThe American Journal of Pathology, 2000
- Epithelial integrinsBioEssays, 1996
- Oxygen metabolite detoxifying enzyme levels in bleomycin-induced fibrotic lungsFree Radical Biology & Medicine, 1988
- Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.JCI Insight, 1987
- Increased DNA chain breakage by combined action of bleomycin and superoxide radicalBiochemical and Biophysical Research Communications, 1975